The specification of an axon and its subsequent outgrowth are key steps during neuronal polarization, a prerequisite to wire the brain. The Rho-guanosine triphosphatase (GTPase) RhoA is believed to be a central player in these processes. However, its physiological role has remained undefined. Here, genetic loss-and gain-of-function experiments combined with time-lapse microscopy, cell culture, and in vivo analysis show that RhoA is not involved in axon specification but confines the initiation of neuronal polarization and axon outgrowth during development. Biochemical analysis and superresolution microscopy together with molecular and pharmacological manipulations reveal that RhoA restrains axon growth by activating myosin-IImediated actin arc formation in the growth cone to prevent microtubules from protruding toward the leading edge. Through this mechanism, RhoA regulates the duration of axon growth and pause phases, thus controlling the tightly timed extension of developing axons. Thereby, this work unravels physiologically relevant players coordinating actinmicrotubule interactions during axon growth.
In Brief
Combining genetic, molecular, pharmacological, and biochemical approaches together with superresolution and live-cell microscopy, Dupraz et al. show that RhoA physiologically limits axon outgrowth by activating myosin-II-dependent actin arc formation to restrict microtubule protrusion toward the growth cone leading edge.
INTRODUCTION
Neurons undergo vivid morphological transitions during their development. From simple, round postmitotic cells, neurons polarize to generate subcompartments that later differentiate into sophisticated structures [1, 2] . Initial polarization is marked by axon formation [3, 4] . This process involves axon specification, singling out one among multiple neurites to become the axon and the subsequent execution of the polarity program by elongation of the specified neurite. How neurons coordinate axon specification and the execution of neuronal polarity is still unclear [5, 6] .
Pioneering work identified the actin cytoskeleton as a key regulator of neuronal polarization and suggested that a dense actin network at the tip of the neurites could restrain axon formation [7] [8] [9] . Destabilization of the actin network lifts this restraint, enabling microtubules to engorge the tip of the neurites and protrude toward the growth cone leading edge, a requirement for neurite growth [7, [10] [11] [12] .
It was postulated early on that the guanosine triphosphatase (GTPase) ras homolog gene family member A (rhoA) could control the stability of the actin network during neuron development [13] . RhoA is thought to promote condensation of the actin network in neurite tips acting as a negative regulator of both axon specification and axon growth [14] and therefore having a role in the establishment of neuronal polarity [5, 13, [15] [16] [17] [18] [19] . Consistently, molecular inactivation of RhoA induces supernumerary axons or axon growth [14, [20] [21] [22] [23] . However, these studies are largely based on the overexpression of mutant dominant-negative (DN) and constitutively active (CA) forms of RhoA, which also scavenge guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) of other Rho GTPases [24] . In this context, it is interesting to note that RhoA deletion in flies (Drosophila melanogaster) or mice does not result in obvious axon trajectory defects [25] [26] [27] [28] , as predicted by overexpression studies [18] . Therefore, although these studies helped to grasp the potential interactome of RhoA, the overexpression approach has limitations to resolve the actual physiological targets [24] . Hence, the physiological role of RhoA during neuronal polarization has remained unexplored [1, 2, 29] .
The interplay of actin and microtubules in the growth cone likely regulates axon growth [11, 30] . Studies on the giant growth cones from stationary axons of cultured Aplysia californica bag neurons have provided insights into neuronal actin-microtubule interactions [10, 31, 32] , which might be extendable to neurons with fast-growing axons. A characteristic cytoskeletal feature in these stationary growth cones are actin arcs, which are a dense meshwork of actin filaments reminiscent of the ventral arcs found in fibroblasts [33] . The actin motor protein myosin II [32, 34] , identified as a candidate regulator of neuron polarity [19] , generates these arcs by compacting actin filaments [10, 35] . Notably, in stationary Aplysia growth cones, actin arcs may be controlled through RhoA [36] . Actin arcs could create a barrier to hinder microtubule forward protrusion [31, 32, 35] . Hence, these structures have the potential to restrain axon growth, which makes them an attractive target for regulating axon extension. Indeed, overexpression studies showed that RhoA could regulate axon growth and that myosin II could be a potential target [19] .
Here, using genetic deletion experiments followed by in vivo and cell culture analysis in combination with time-lapse and high-resolution microscopy, we demonstrate that axon specification is independent of RhoA. However, RhoA regulates the onset and timing of neuronal polarization. Specifically, we show that RhoA, by controlling microtubule protrusion into the growth cone periphery through myosin-II-generated actin arcs, instructs the duration of growth and pause phases that dictate the speed of axon outgrowth.
RESULTS

RhoA Regulates Neuronal Polarization by Restraining Axon Initiation and Growth, but Not Axon Specification
To assess the physiological function of RhoA during neuronal polarization, i.e., axon specification, axon initiation, and axon growth, we generated mice with conditional CNS-targeted deletion of RhoA (nestin-cre tg/À , RhoA fl/fl ; termed hereafter RhoA KO). Immunoblot analysis showed that the RhoA protein was undetectable in brain extracts from embryonic day (E) 16 RhoA KO embryos ( Figure 1A ). RhoA KO brains had several abnormalities compared to brains from control littermates, including enlarged ventricles with uneven cellular organization at their surface ( Figure 1B) accompanied by a thin cortical plate (CP) and compacted lamination ( Figure 1C ).
To investigate the involvement of RhoA in axon specification, we tested whether neurons in RhoA KO brains contained supernumerary axons. To characterize the three-dimensional morphology of RhoA KO neurons, we cleared adult brains of RhoA KO mice that were crossed with the GFP-M mouse line, in which neurons are sparsely labeled throughout the brain (nestin-cre tg/À , RhoA fl/fl , gfp-m tg/À ; termed hereafter RhoA KO[GFP]) [37, 38] . Two-photon microscopy of the cleared cortex and hippocampus showed that RhoA KO [GFP] neurons feature only a single axon emanating from their cell body, as found in neurons from control WT[GFP] mice (nestin-cre À/À , RhoA fl/fl , gfp-m tg/À ; Figures 1D-1F ; Videos S1 and S2).
The possibility remained that, in the absence of RhoA, neurons would form supernumerary axons early during development that would be pruned at a later time point. To test this, we electroporated the brains of RhoA fl/fl embryos in utero with a plasmid (E and F) Quantification of (D). Average percentage of neurons with single axons in the cortex (E) and hippocampus (F) of WT and RhoA KO brains is shown. See also Figure S1 and Videos S1 and S2. Values are plotted as mean ± SEM; ns, not significant by Student's t test. WT, N = 290; RhoA KO, N = 176 neurons from n = 7 and n = 6 cortices, respectively; WT, N = 91; RhoA KO, N = 125 neurons from n = 4 and n = 5 hippocampi, respectively. encoding Cre recombinase under the control of the neuron-specific tubulin-alpha-1 promoter (pTa1-Cre) together with a loxP GFP (Zoanthus sp. (Zs)Green)-based recombination reporter plasmid ( Figure 2A ). Thereby, recombination only occurs in neurons. Hence, the generated RhoA KO neurons develop in a wildtype (WT)-like environment. As a control, we electroporated a plasmid encoding Dre integrase driven by the same Ta1 promoter (pTa1-Dre) together with a roxP GFP (ZsGreen)-based reporter plasmid, leading to MOCK recombination ( Figure 2A ). Cre recombinase-mediated deletion of RhoA by electroporation at E13.5 led to more rapid neuronal migration (Figures S1A and S1B), confirming previous results [28] , and the near absence of RhoA in biochemical extracts of RhoA fl/fl cortical neurons within 1 day in vitro (DIV) ( Figure S1C ). Importantly, neuronal polarization was not affected. RhoA KO and WT neurons in the CP of E15.5 electroporated brains displayed a typical polarized bipolar (BP) morphology (83.3% ± 1.1% versus 85.1% ± 2.1%, respectively; p = 0.52; Figure S1D ) characterized by one leading process and a single trailing process, which will later become the axon ( Figure S1E ) [39] . Hence, axon specification is independent of RhoA. Next, we investigated the role of RhoA in axon initiation and growth. To analyze early axon formation in vivo, we electroporated RhoA fl/fl embryos at E12.5, allowing axons from recombined neurons to elongate as pioneer axons [3] , and analyzed their trajectories at E14. 5 Dissociated RhoA KO hippocampal neurons recapitulated the in vivo phenotype and showed a more rapid polarization ( Figures  3A and 3B ). As early as 12 h after plating, more than twice as many RhoA KO neurons contained an axon positive for the axonal marker Tau-1 compared to WT control neurons (Figure 3C; 39.5% ± 4.3% versus 16.9% ± 4.5%, respectively; p < 0.0001). Axons of RhoA KO neurons were also longer than those generated by WT neurons ( Figure 3D ). At later time points, WT neurons also formed an axon ( Figure 3E ), but axons of RhoA KO neurons continued to be substantially longer ( Figure 3F ). Interestingly, in RhoA KO neurons, the onset of spontaneous excitatory postsynaptic currents (sEPSCs) was detected earlier compared to WT neurons, suggesting an acceleration of synaptic maturation. Already at 4 DIV, 13 .3% (4 out of 30) of RhoA KO neurons showed sEPSCs, which were not detected in WT neurons (0 out of 29; Figures S2B and S2C ). After 7 DIV, 85% (17 out of 20) of cultured RhoA KO neurons showed sEPSCs compared to only 38.9% (7 out of 18) of WT neurons ( Figures  S2B and S2C ). Moreover, RhoA KO neurons showed a higher frequency of sEPSCs than WT neurons (RhoA KO, 2.2 ± 0.8 Hz versus WT, 0.2 ± 0.1 Hz; p < 0.001; Figure S2D ), while the amplitudes of the sEPSCs were similar between WT and RhoA KO neurons (96.2 ± 30.5 pA versus RhoA KO, 81.4 ± 10.3 pA, respectively; p = 0.74; Figure S2E S2F). Re-expression of RhoA in RhoA KO neurons restored a shorter axon equal to WT neurons ( Figures 3K and 3L ). Consistent with our in vivo results, we did not observe differences in the number of neurons bearing multiple axons between WT and RhoA KO cultures (2.9% ± 1.3% versus 4.0% ± 1.0%, respectively; p = 0.52; Figure S2G ). Interestingly, WT neurons treated with C3 exoenzyme, which inactivates all RhoA, RhoB, and RhoC [40] , showed a growth pattern indistinguishable from RhoA KO neurons, suggesting a prominent role for RhoA at this stage of axon development ( Figures 3B-3F ). Notably, additional inactivation of RhoB and RhoC by C3 exoenzyme in RhoA KO neurons did not increase the number of neurons containing multiple axons (RhoA KO versus RhoA KO+C3T; 4.0% ± 1.0% versus 6.5% ± 1.3%, respectively; p = 0.09; Figure S2G 
Non-muscular Myosin II Is a Physiological Target of RhoA during Neuronal Polarization
To determine the physiologically relevant effectors downstream of RhoA that restrain axon growth, we first assessed RhoA crosstalk with other related Rho-GTPases. Cdc42 and Rac1 are known promoters of axon growth whose genetic ablation severely impairs axon outgrowth [41, 42] . We examined the protein level and activation state of Cdc42 and Rac1 in biochemical extracts of cultured cortical RhoA KO neurons and found them to be similar to WT neurons ( Figures S3E-S3G ). RhoA activates Rho-associated, coiled-coil-containing protein kinase (ROCK) as its immediate downstream target [43] ( Figure 4A ). Consistently, in biochemical extracts from cultured cortical RhoA KO neurons, ROCK activity decreased compared to WT extracts ( Figure 4B ). Overexpression studies in cell lines have previously shown that activated ROCK phosphorylates LIM domain kinase (LIMK) [44, 45] , which in turn regulates cofilin activity [46, 47] (Figure 4A ). Moreover, cofilin drives neurite formation [48] and axon regeneration in the CNS [49] . However, immunoblot analysis of extracts from cortical neuronal cultures revealed no difference in the level of phosphorylated (p)-LIMK or of p-cofilin between WT and RhoA KO neurons ( Figures 4C-4F ). Immunocytochemistry confirmed that the p-cofilin/cofilin ratio in the growth cone was similar between WT and RhoA KO hippocampal neurons ( Figures 4G and 4H ), further suggesting that RhoA does not regulate axon growth through cofilin.
ROCK also activates myosin II by directly phosphorylating its regulatory myosin light chain (MLC2) and also indirectly by phosphorylation of the regulatory myosin phosphatase target subunit-1 (MYPT-1) of the myosin phosphatase [50, 51] ( Figure 4A ). Indeed, immunoblot analysis of cultured cortical neuronal extracts and immunocytochemistry showed that both p-MYPT-1 and p-MLC2 levels decreased in RhoA KO compared to WT hippocampal neurons ( Figures 4I-4N ). Hence, myosin-II-actinmediated restraint could be a potential physiological regulator of axon growth downstream of RhoA.
Myosin II Restrains Axon Growth Downstream of RhoA
Inactivation of myosin II in hippocampal WT neurons by using 20 mM blebbistatin (Blebb) leads to the generation of supernumerary axons ( Figure S3H ), consistent with previous reports [23, 52] . As myosin II was only partially inactivated in RhoA KO neurons, we asked whether a moderate decrease in myosin II activity could recapitulate the RhoA KO phenotype by enhancing onset and rate of neuronal polarization without perturbing axon specification. WT hippocampal neurons treated with 0. We asked next whether the growth enhancement found after myosin II inhibition could be recapitulated by actin destabilization. Indeed, similar to myosin II inhibition, destabilizing the actin cytoskeleton with high latrunculin A (Lat A) doses (25 nM) led to the formation of supernumerary axons ( Figures S3H and S4A ), while modest Lat A doses (5 nM) accelerated the onset of axon initiation and enhanced the growth of a single axon, hence maintaining polarity ( Figures S4A-S4D ). Thus, mild actin instability caused by partial inhibition of myosin II activity drives the enhanced axon growth of developing RhoA KO neurons.
RhoA Drives Actin Arc Formation in the Growth Cone through Myosin II
As the machinery for axon growth is thought to be located in its growth cone, we characterized the growth cone cytoskeleton in RhoA KO neurons. Phalloidin staining of fixed co-cultures of WT and RhoA KO hippocampal neurons ( Figure S6A ) revealed a comparable amount and a similar distribution of polymerized fibrous (F)-actin between WT and RhoA KO neurons ( Figure 6A ). The balance between soluble globular (G) actin and F-actin has previously been proposed to be an indicator of gross changes in growth cone cytoskeleton dynamics and axon growth [48] . An equal G/F-actin ratio was found between biochemical extracts from WT and RhoA KO neuronal cultures (Figures 6B and 6C). Importantly, however, stimulated emission depletion (STED) microscopy revealed structural differences in growth cone actin architectures. Although the majority (83.3% ± 0.9%) of WT neurons contained actin arcs in their axonal growth cone, these structures were present in few RhoA KO growth cones (23.2% ± 0.5%; p < 0.0001; Figures 6D and 6E ). Moreover, F-actin bundles in WT growth cones were prominent at the peripheral (P)-domain of the growth cone and terminated within the actin arc structures at the transition (T)-domain. In RhoA KO growth cones, by contrast, F-actin bundles were longer and many spanned from the leading edge to the base of the growth cone ( Figures 6D and 6F ).
Pharmacological myosin II inactivation reproduced the RhoA KO growth cone morphology. WT hippocampal neurons treated with 0.5 mM Blebb lacked actin arcs in their growth cones (30.8% ± 0.9% versus 83.3% ± 0.9% for Blebb versus WT, respectively; p < 0.01), similar to the decrease detected in growth cones of RhoA KO neurons ( Figures 6D and 6E ). Moreover, the F-actin bundles of Blebb-treated WT growth cones were longer compared to the F-actin bundles of WT growth cones but similar to those of RhoA KO growth cones ( Figures  6D and 6F ). Conversely, overexpression of constitutively active form (MLC2-CA) in RhoA KO neurons restored actin arc formation to WT-like levels ( Figures S5G and S5H ). Thus, RhoA generates actin arcs in the growth cone through myosin II.
Myosin-II-Generated Actin Arcs Downstream of RhoA Impede Axon Growth by Restraining Microtubule Protrusion
In growth cones of mouse pyramidal neurons ( Figure S6B ), actin retrograde flow speed decreases at the T-domain, relative to the P-domain, as actin filaments become compressed against the actin arcs, recapitulating processes of stationary Aplysia growth cones [10] . Given the loss of actin arcs and the extension of F-actin bundles into the central (C)-domain in RhoA KO growth cones, we hypothesized that centripetal movement of actin filaments might therefore be unrestricted and turnover more rapidly. Indeed, time-lapse imaging of actin dynamics in growth cones from hippocampal RhoA KO neurons transfected with Lifeact [53] ( Figure 7A ) showed increased retrograde flow compared to WT growth cones ( Figure 7B ). Myosin II inactivation recapitulated the RhoA KO phenotype: actin retrograde flow in the P-domain of the growth cone was enhanced in Blebb-treated WT neurons, reaching speeds comparable to RhoA KO neurons ( Figure 7B ). Moreover, the speed of actin retrograde flow in the T-domain of growth cones of RhoA KO neurons was significantly higher than the actin retrograde flow measured in WT neurons but similar to Blebb-treated WT neurons (6.02 ± 0.14 mm/min versus 5.92 ± 0.12 mm/min versus 5.52 ± 0.12 mm/min, respectively; WT versus RhoA KO p < 0.05; WT versus Blebb p < 0.05; RhoA KO versus Blebb p = 0.59; Figure 7B , right). This finding raises the possibility that increased actin retrograde flow in the growth cone T-domain reflects the disassembly of the actin arc barrier, which might lead to a less-efficient retention of microtubules in the C-domain.
We therefore studied microtubule advance in neurons expressing end-binding protein 3 (EB-3), a marker of polymerizing microtubule ends, fused to mCherry [48, 54] ( Figure 7C ). In both RhoA KO and Blebb-treated WT growth cones, we found that microtubule advance speed in the P-domain was higher compared to WT growth cones ( Figure 7D ). As a result, microtubules reached closer to the leading edge of RhoA KO and Blebb-treated WT growth cones compared to vehicle-treated WT growth cones (Figures 6D, 7C, and 7E; Video S5). Similarly, growth cones of fast-elongating Lat-A-treated axons showed a disorganized actin network without actin arcs ( Figures  S4E-S4G ). This, in turn, led microtubules to reach closer to the growth cone leading edge compared to the microtubules in vehicle-treated growth cones ( Figures S4E and S4H-S4J ). These findings further support the hypothesis that RhoA impedes axon growth by restraining microtubule protrusion into the P-domain of the growth cone. To test this hypothesis directly, we deduced that moderate microtubule destabilization should reverse the enhanced axon growth observed in RhoA KO neurons. Indeed, cultured RhoA KO neurons with low doses of the microtubule-destabilizing drug nocodazole (50 nM) decreased their axonal lengths to measurements found in WT control neurons ( Figures 7F and 7G ). Hence, modest microtubule destabilization in RhoA KO neurons restores WT-like neuronal morphology. Thus, RhoA restrains axon growth by confining microtubules to the central growth cone domain through myosin-II-generated actin arcs ( Figure S7A) .
DISCUSSION
Polarization is a hallmark of neuronal development. It involves the specification of the future axon from several minor neurites and the execution of a growth program in the specified neurite through accelerated growth. Here, we demonstrate that RhoA is not required for axon specification, but it decelerates neuronal polarization in the developing mammalian brain. RhoA restrains neuronal polarization and axon growth by inducing myosin-II-generated actin arcs to prevent microtubule protrusion in the axonal growth cone. We will discuss in detail how these findings change our perspective on neuronal polarization.
The Physiological Role of RhoA during Neuronal Polarization
The Rho-GTPases Cdc42 and Rac1 cause actin rearrangements that favor neurite outgrowth and axon formation [9, 41, 42, 55] , whereas high RhoA activity was thought to prevent minor neurites from becoming axons [1, 5, 16, 56, 57] . Strikingly, our data demonstrate that RhoA is not involved in axon specification. RhoA KO neurons achieved the prototypical polarized architecture: they contained a single axon and multiple dendrites both in culture and in vivo during development, as well as in the adult brain. Instead, RhoA is involved in the onset and timing of neuronal polarity. Our analyses of RhoA KO neurons in the developing brain as well as in cell culture pinpoints RhoA as a physiological growth brake that limits axon initiation and enables axon growth pauses. Axons have previously been observed to grow in spurts interrupted by pausing events [4, 58] , which are less frequent in RhoA KO neurons. The periodic axon growth mediated by the RhoA-controlled growth brake could facilitate synchronization of axon elongation with the supply of building blocks necessary for growth. Moreover, as a premature arrival of axons would be disruptive for neuronal circuitry [59] , slowing down axon growth may help the brain to mature in a coordinated fashion. In line with this concept, our data also indicate that RhoA could restrain the functional maturation of axons, delaying the onset of synaptic activity. We anticipate that decelerating axon growth and maturation might play a prominent role in the nervous system of mammals with long gestation periods, including humans, where axons grow relatively slowly [60] .
Actin Arcs, the Physiological Brake to Axon Growth Actin filaments and microtubules may generate two counteracting forces to keep axon growth in balance [11, 30, 61, 62] . Whereas actin filaments can create structures in the growth cone that halt axon elongation, protruding microtubules propel axon growth [48, [63] [64] [65] . What are the molecular mechanisms that allow conversion between axon growth and growth cone arrest? Using STED microscopy to investigate embryonic mouse neurons, we detected actin arcs in the majority of WT growth cones, which previously have mainly been associated with the growth cones of stationary axons, such as those of Aplysia bag neurons [10] . This was in contrast to RhoA KO neurons, where only a few growth cones contained actin arcs, which initiated and extended axons quickly. Thus, actin arcs appear to be indicators of pausing axons.
The microtubule array in RhoA KO growth cones responded to the reorganization of their actin cytoskeleton. Microtubules in RhoA KO growth cones projected in bundles through a corridor-like structure flanked by actin filaments, an organization previously described for axons during the elongating phase [11] . Compared to microtubules in WT growth cones, microtubules in RhoA KO growth cones experienced less hindrance through the T-domain and, consequently, reached the growth cone's leading edge more frequently. The resulting faster growth of axons in RhoA KO neurons can be reversed by modest microtubule destabilization. Thus, RhoA regulates axon growth by controlling microtubule protrusion through the gating activity of actin arcs in the growth cone.
Myosin II, the Physiological Instructor of Actin Arcs Downstream of RhoA Restraining Axon Growth
Various signaling pathways and effector molecules downstream of RhoA were discussed as candidate regulators of neuronal polarity, including profilins, formins, ADF/cofilin, and myosins [2, 5, 17, 30, 66] . Our work demonstrates that genetic inactivation of RhoA leaves the G/F-actin ratio intact while leading to a partial inhibition of myosin II. This causes a decrease in actin arc formation along with microtubule protrusion to the axonal growth cone leading edge and accelerated axon growth without affecting axon specification. The partial inhibition of myosin II in RhoA KO neurons is likely due to its multiple sources of activation and deactivation, some of which are RhoA dependent, including ROCK and MYPT-1, whereas others are RhoA independent, including the myosin light chain kinase (MLCK) [67] . In fact, the RhoA KO phenotype is fully recapitulated by low doses of Blebb treatment. It argues that RhoA is less promiscuous during neuronal polarization than previously thought, revealing myosin II as the central physiologically relevant target.
Of note, the pool of inactivated myosin in neurons includes the highly expressed myosin IIB isoform and also myosin IIA, which is present at lower levels [19, 68, 69] . Myosin IIB and IIA differ in their kinetic properties, but they show overlapping functions [68] and undergo isoform-specific reorganizations in the axonal growth cone, depending on their growth substrates [35] . Given its expression levels in developing neurons, myosin IIB is likely to be a more relevant target effector for RhoA than myosin IIA. In this line, similar to RhoA ablation, deletion of myosin IIB or its replacement for a motor-impaired myosin IIB mutant during embryonic development leads to the destabilization of adherens junctions in the ventricular surface, resulting in the enlargement of the cerebral ventricles (hydrocephalus) [68, 69] . Future studies will decipher the specific contributions of these myosin isoforms to the regulation of neuron polarity.
In polarizing neurons, the actin network in the nascent axon is more susceptible to destabilization than that of future dendrites, an imbalance required to single out a fast-elongating axon [7] . Our data suggest that partial inhibition of myosin II or mild destabilization of the actin network, both contributing to relax the actomyosin system, leave the polarity program intact while facilitating its execution through early onset of axon formation and enhanced axon elongation. On the contrary, strong destabilization of the actomyosin system, by high doses of the myosin II inhibiting agent Blebb as well as actin-depolymerizing drugs, simply overrides the polarity program enabling multiple neurites to become axons [7-9, 23, 52] . It is interesting to consider the possibility that, besides its role as gatekeeper at the T-domain of axonal growth cones, the actomyosin system could also act globally as an intracellular corset that guides intrinsic neuronal polarization. Consistent with this view, the RhoA-dependent actomyosin cortical network is required to initiate membrane extensions during polarized growth in endothelial cells and in tumor-derived cell lines [70] [71] [72] . Thus, molecular manipulations that only relax but do not demolish the actin-myosin network would favor axon growth but still preserve polarity.
Conclusions
Multiple candidate molecules with promising instructive roles in early axon development have been identified. It has remained challenging, however, to unambiguously distinguish between molecules with essential roles in axon specification and those required only to regulate axon growth [73] . Here, we show that the physiological role of RhoA in neuronal polarization is to restrain the onset and the rate of axon growth, but not to specify the axon. RhoA functions by activating myosin II, which enables compaction of actin filaments to form actin arcs in the T-zone of the growth cone. These actin arcs restrain microtubule protrusion and, consequently, axon growth. Thus, this work defines a physiologically relevant molecular brake of axon growth during development.
It is noteworthy that the last two decades have seen enormous efforts to exploit the RhoA/ROCK pathway as a therapeutic tool to alleviate pathological and traumatic CNS conditions by inducing axon regeneration [74] [75] [76] . Given that axon regeneration is hypothesized to be a recapitulation of developmental processes [77] and that the cytoskeleton plays a key role during axon regeneration [64, 78, 79] , this work has laid a promising basis to better understand the molecular mechanisms that could lead to axon regeneration.
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STAR+METHODS KEY RESOURCES TABLE
LEAD CONTACT AND MATERIALS AVAILABILITY
The plasmids generated in this study have been deposited to Addgene (see Table S2 ). Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Frank Bradke (frank.bradke@dzne.de). There are no restrictions on any data or materials presented in this paper.
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All animal experiments were performed in accordance with the Animal Welfare Act and the guidelines of the North Rhine-Westphalia State Environment Agency (Landesamt fü r Natur, Umwelt und Verbraucherschutz (LANUV)). The animals were group housed (up to 5 mice per cage) with room temperature controlled at 21-22 C, and an artificial 12-h light:dark cycle (lights off at 6:00 pm). Mice were given food and water ad libitum throughout the experiment. Nestin-Cre driver line [81] to generate nes-cre tg/-, RhoA fl/wt mice that were subsequently crossed with homozygous RhoA fl/fl mice. The mating yielded embryos with genotypes in the expected Mendelian ratios including nes-cre tg/-, RhoA fl/fl , here on referred as RhoA KO, and nes-cre À/À , RhoA fl/fl control littermates here on referred as WT. To obtain sparse GFP neuronal labeling in adult RhoA KO mice, we first generate RhoA fl/fl ,gfp-m tg/tg mice by mating RhoA fl/fl and gfp-m tg/tg [82] to obtain a RhoA fl/wt ,gfp-m tg/-F1. F1 mice were then inter-crossed until obtaining progeny that showed homozygosity for both transgenes. These mice were then crossed with nes-cre tg/-,RhoA fl/wt mice to obtain RhoA KO[GFP] (nes-cre tg/-,RhoA fl/fl ;gfp-m tg/-) and WT[GFP] (nes-cre À/À ,RhoA fl/ fl ;gfp-m tg/-) mice. Mice ubiquitously expressing enhanced green fluorescent protein (EGFP)-mice under a ''CAG'' promoter [83] were from the Jackson laboratory. All mice were kept on a C57BL/6J background.
METHOD DETAILS
Neuronal Cell Culture Cell Culture Primary hippocampal neurons were obtained from embryonic day 16.5 (E16.5) to E17.5 mouse embryos. Glia-free cultures were performed similarly to as previously described [84] . In brief, after dissection, hippocampi were collected in HBSS (Thermo Fisher). For RhoA KO cultures, we followed the same procedure but processing the hippocampi from individual embryos separately to maintain genetic identity of the subsequent cultures. Next, hippocampi were digested in trypsin 0.05% (Thermo Fisher) for 15 min and the reaction was stopped by addition of MEM-horse serum (MEM-HS) media [1X MEM, 1X essential and non-essential amino acids, 2mM L-glutamine (all from Thermo Fisher), 0.22% NaHCO 3 , 0.6% glucose and 10% horse serum (Pan-Biotech)]. Hippocampi were then mechanically dissociated with fire-polished glass-Pasteur pipettes. Dissociated neurons were plated either at low (71 cells/mm 2 ) or high (350 cells/mm 2 ) density for visualization experiments or biochemistry, respectively. For all culture conditions, neurons were allowed to attach to Poly-L-lysine-coated coverslips in the presence of MEM-HS for 2 h, which was then replaced for neuronal media (N2) (1X MEM, sodium pyruvate 1 mM, Neuropan 2 supplement 1% (Pan-Biotech), NaHCO 3 , 0.6% glucose, 2 mM L-glutamine) pre-conditioned by 2-3 days incubation with a feeder layer composed of WT glia. While glia-conditioned N2 was used in short-term cultures (12-48 h) , long-term cultures (> DIV 4) required continuous support of a glial feeder layer [84] .
Drugs treatments were carried out during the change to neuronal glia-conditioned N2 media [Blebbistatin 0.5 mM and 20 mM (Sigma), Latrunculin A 5 nM and 25 nM (Biomol), Nocodazole 50 nM (Sigma) and C3T 0.5 mg/ml (Cytoskeleton)]. Glia-conditioned N2 containing the C3T was replaced for fresh glia-conditioned N2 4 h after addition following manufacturer's recommendations. To note, extra care has to be taken to dilute nocodazole to avoid precipitation, which can cause toxicity and high variability in the drug's effective concentration.
Mixed WT [green fluorescent protein (GFP)-positive]/RhoA KO (GFP-negative) cultures were performed similarly to as previously described [85] . In short, embryonic hippocampal neurons isolated from RhoA KO embryos were cultured alongside with WT neurons ubiquitously expressing EGFP obtained from age-matched EGFP-mice embryos [41, 83, 85] .
Unless otherwise indicated, the immunocytochemistry experiments are performed with cultured hippocampal neurons and the neuronal extracts for immunoblot analysis were prepared from cultured cortical neurons.
For the combined expression of LifeAct-GFP and EB3-mCherry under independent promoters, a dual CMV promoter vector (pCMV-EB3mCherry_cmv-LifeActGFP) was generated as follow: A CMV-LifeAct-GFP-polyA cassette was amplified from Lifeact-GFP [53] with primers SpeI-CMV-forward 5 0 -and BglII-EGFP-reverse (see Table S1 ), and inserted in SpeI/Bglll sites of pCAGIG (pCMV-lifeAct-GFP). Then, a CMV-EB3-mCherry-polyA cassette was amplified from a EB3-mCherry plasmid [54] with primers SalI-CMV-forward and SpeI-sv40-reverse (see Table S1 ), and cloned in SalI/SpeI sites of pCMV-lifeAct-GFP prepared before. Finally, to generate a pTub-alpha1-EGFP, a pTub-alpha-1-DsRED vector was digested with NdeI/BamHI to release the Ta1 sequence that was subsequently cloned into a pCMV-EGFP-N1 vector (Clontech) where the CMV promoter was removed by digestion with AseI/BglII. All these complementary restriction sites were destroyed. All primers were from Sigma. PCRs were performed with Phusion High-Fidelity PCR Master Mix (New England Biolabs). Vector Cloning was performed following the Gibson assembly method using the NEBuilder HiFi DNA Assembly Cloning Kit (New England Biolabs), or regular T4 ligase-based cloning (Thermo Fischer).
For gene silencing experiments, siRNA oligos (SilencerÒ Select) and RNAi negative control were purchased from Thermo Fisher (see Table S2 ).
Cell Transfections
Cell transfections were performed using a Nucleofector Device (program 0-005, Lonza) and the mouse neuron NucleofectorÒ Kit (Amaxa) according to the manufacturer's specifications. 5 3 10 5 cells were used for each transfection with 3 mg of plasmid DNA. All DNAs were prepared with EndoFree Maxiprep kit (QIAGEN). For the silencing experiments, 5 3 10 5 cells were transfected with a mix of 0.2 pmol of the siRNA and 1 mg of neuron-specific GFP expressing plasmids (pTub-alpha1-EGFP) as carrier DNA and transfection reporter.
Antibodies and dyes Antibodies
The following primary antibodies were used: Mouse anti-bIII tubulin (Tuj1, Covance), rabbit anti-bIII tubulin (Sigma), mouse anti-Glyceraldehyde 3-phosphate Dehydrogenase (GAPDH, Acris), mouse anti-Tau1 [PC1C6] (Millipore), rabbit anti-Myosin Heavy Chain IIB (Cell Signaling), mouse anti-LIMK (BD biosciences), rabbit anti-LIMK1/2 phospoThr508/505 (Cell Signaling), rabbit anti-RhoA (Cell Signaling), rabbit anti-RhoB (Cell Signaling), rabbit anti-RhoA (119) (Santa Cruz), mouse anti-Rac1 [23A8] (Millipore), mouse anti-Cdc42 (Cytoskeleton), rabbit anti-Cofilin [D3F9] (Cell Signaling), rabbit anti-Cofilin phospho (Ser3) [77G2] (Cell Signaling), mouseanti Cofilin (Abcam), rabbit anti-Myosin light chain 2 (MLC2) (Thermo Fisher), mouse anti-MLC2 (phospho-Ser19) (Thermo Fisher), rabbit anti-MLC2 (phosphor-Ser20) (Abcam), mouse anti-MYPT-1 (BD biosciences), rabbit anti-MYPT-1 (phospho-Thr696) (Cell Signaling), mouse anti-SatB2 (Abcam), rabbit anti-Tbr1 (Abcam), rat anti-Ctip2 [25B6] (Abcam). The following secondary antibodies and dyes were used: Alexa Fluor (488, 350, 647, 594 and 568), Phalloidin-Rhodamine and 4',6-diamidino-2-phenylindole (DAPI) were from, Thermo Fisher.; anti-mouse IgG-horse radish peroxidase (HRP) and anti-rabbit IgG-HRP were from (GE Healthcare); Phalloidin-Atto647N and mouse-IgG-Atto 647N were from Sigma.
Immunocytochemistry
Neuronal cultures were fixed with 4% paraformaldehyde, 4% sucrose for 20 min except for cultures used for STED microscopy, where fixation was performed under conditions optimal for the preservation of the cytoskeleton: 4% paraformaldehyde, 4% sucrose in PHEM fixation buffer (300 mM PIPES, 125 mM HEPES, 50 mM EGTA, 10 mM MgCl 2 , pH = 6.9 [63] ; for 15 min. Fixed cells were quenched with 50 mM NH 4 CL or 0.1 M Glycine (for fixation with PFA or PHEM respectively) for 15 min and extracted with 0.1% Triton X-100 in PBS for 5 min. The coverslips with the cells were washed three times with PBS then blocked at room temperature (RT) for 1 h. Depending on the antibodies used, blocking agents were 3% Bovine Serum Albumin (BSA, Sigma; for the antibodies bold-highlighted in the list above), blocking buffer (2% Fetal Bovine Serum (FBS, Thermo Fisher), 2% BSA and 0.2% fish gelatin (Sigma) in PBS) or (Acetylated BSA (BSA-c, Aurion) for STED experiments. After blocking, cells were incubated with the primary antibodies at RT for 3 h or overnight at 4 C. Cells were washed three times with PBS and incubated with the secondary antibodies (1:800) at RT for 1 h. The antibodies and dyes were mixed in a 1:10 dilution of the agent used in the blocking step. Cells were washed, rinsed and mounted onto microscope slides with Fluouromount TM (Sigma) or, for STED experiments, with ProLong TM Diamond (Thermo Fisher). Images were taken in a random fashion using an Axiovert observer D1 microscope equipped with a high performance CCD camera (Axiocam MRn) and Zen Blue software (all from Zeiss) with the following objectives: LCI Plan-Neofluar 25X/0.8 oil, Plan-Apochromat 40X/1.3 oil, Plan-Apochromat 63X/1.4 oil, and A Plan-Apochromat 100X/1.4 oil. STED Microscopy STED images were acquired with a TCS SP8 STED 3X equipped with a 775 nm depletion lasers and a HCX PL APO 100X/1.4 oil Objective (Leica) using the Leica Application suite X (LAX) 3.1.5.1638 software platform. Probes labeled with AlexaFluor 647 and Atto647N were excited with the 647 nm wavelength of a white light laser (WLL) and depleted with a continuous wave (CW) 775 nm STED laser. Probes labeled with AlexaFluor 594 were excited with the 594 wavelength of a WLL laser and depleted with a CW 775 nm STED laser. Hybrid detectors (HyD, Leica) were used with a gating time (tg) of 0.3 % tg % 6 ns. Pixel size was chosen at 20 nm. STED images were deconvolved using Huygens Professional Deconvolution software (Scientific Volume Imaging, Netherlands). Images were analyzed using ImageJ software (NIH). one minute with a holding potential of À60 mV. sEPSC detection was carried out with the Axon clampfit 11 template search tool (Molecular Devices).
QUANTIFICATION AND STATISTICAL ANALYSIS Quantification
Data analysis was performed as follows: In culture experiments ( Figures 3B-3L , 5A-5E, 7F, 7G, S2G, S3B-S3D, S3H, S3I, S4A-S4D, and S5A-S5F), neurons without neurites or showing neurites shorter than 10 mm were considered as stage 1 (no neurites). Neurons showing neurites longer than 10 mm without medial-to-distal accumulation of Tau-1 were considered as stage 2 (not polarized). A neurite displaying a medial to distal accumulation of the axonal marker Tau-1 was considered an axon. Neurons that elaborate an axon were stage 3 (polarized). Neurons exhibiting multiple axons were also considered stage 3 neurons. Total axon length refers to the length covered by the main axon shaft plus its branches.
To analyze axon growth in time-lapse video-microscopy ( Figures 5F-5H) , the axon of the neurons is identified at the end of the video, the video is rewind and the length of the neurite that originated it was measured over time using ImageJ. In this experiment, only the length of the main axon shaft was analyzed.
To resolve the kinetic components of axonal growth (Figures 5G, 5H , and S3J), a custom-made script (see Key Resources Table) was generated to detect growth events (one or more followed events resulting in length increases > 5 mm with tolerance for single intermediate drop event < 1 mm), retraction events (one or more followed events resulting retractions > 5 mm in length with tolerance for single intermediate increase event < 1 mm) and pause events (considered as followed events with length variations < 0.1 mm).
In culture cell experiments where axonal markers were not employed, the longest neurite of the neuron, at least 50 mm long, was considered the axon ( Figures 4G, 4H , 4M, 4N, 6D-6F, 7A-7E, S4E-S4J, S5G, and S5H).
In experiments where we study the formation of actin arcs in growth cones ( Figures 6D, 6E , S4E, S4F, S5G, and S5H) we considered that a growth cone contained actin arcs when transversal actin dense structures, perpendicular to the exe of microtubule growth, were present and microtubules showed preferential retention within the P-domain.
The density and extension of axon from electroporated neurons in cortical slices ( Figures 2B and 2C) were determined as follows: The limit of the electroporated area was defined as the region where the fluorescent signal is below 10% of the maximum intensity of the whole electroporated area. Starting from this limit, a ROI was created containing the axons exiting caudally from the IZ (Figure 2C , diagram). The images were then processed to transform the fluorescent signal of axons into binary lines independent of the amount of fluorophores expressed by individual axons. For this, we used a macro containing the following functions from ImageJ: Tubeness/ Gaussian blur/Binary mask/Skeletonize. The resulting images were analyzed with the linescan/plot profile tools of ImageJ to determine the density of axons as the measured signal intensity. We performed this analysis for 2 consecutive brain slices to better span the entire electroporated area and the values were averaged. Note that in one of the RhoA KO brains, three consecutive slices were required for the analysis. Followed, we calculated the average distance covered by axons emanating from the electroporated region (ER) for each brain. Then, we calculated the groups mean variance between WT and KO axons and the variance within treatments. The resulting data were analyzed with a Custom ANOVA test (F-test). For all images, a corresponding mask of DAPI staining was used to correct for ruptures and discontinuities in the tissue.
In organotypic cultures derived from ex utero electroporations ( Figures 2D-2F) , we started the time counting when a neuron showed the first signs of MP morphology and terminated when the neuron acquired a stable BP morphology. We considered the end of the MP-BP transition of neurons as the onset of neuronal polarity.
To determine the presence and number of axon per neuron (polarity) in the cortex and hippocampus of cleared adult brains ( Figures  1D-1F ) as well as in the cortical plate of embryonic brains derived from in utero electroporations ( Figures S1A and S1D) , we counted all neurons in selected regions and sorted them in two groups: 1) neurons ''with single axon,'' those neurons displaying long axons or showing a clear bipolar morphology (showing leading and trailing processes), and 2) with ''no axon detected,'' where by reasons of low reporter signal or tissue damage we could not determine unambiguously the presence or absence of an axon or trailing process. Therefore, we cannot exclude that a neuron labeled ''no axon detected'' may indeed have an axon. In none of the cases we found a neuron with more than one axon.
Statistical Analysis
Statistical analysis was performed using Prism (v. 6.0; GraphPad Software) as follows: unpaired two-tailed Student's t test ( Figures  1E, 1F , 2F, 4B, 4D, 4F, 4H, 4J, 4L, 4N, 6C, 7D (black asterisks), S1D, S3H, S4A-S4D, S4F-S4H, S4J, and S5H); Mann-Whitney-test ( Figures S2D and S2E) ; multiple comparison by one-way ANOVA with Tukey's post-test ( Figures 3H, 3J , 3L, 5H, 6E, 6F, 7D (red asterisks), 7G, S2G, S3C, S3D, S3I, S3J, S5B, S5C, S5E, and S5F); ordinal logistic regression integrating time progression and correction for experimental variability (Figures 3C, 3E , 5B, and 5D; see Key Resources Table) ; generalized linear model (GLM) using a Gamma distribution to account for the non-negative range of the length plus correction for confounding effects of the individual experiments ( Figures 3D, 3F , 5C, and 5E; see Key Resources Table) ; two-way ANOVA with Tukey's post-test ( Figures 5G and 7E) ; customized ANOVA test (F-test) ( Figure 2C ; see Key Resources Table) ; custom-made Fisher's permutation test corrected for multiple comparison error by Benjamini-Hochberg procedure ( [93] ; see Key Resources Table) ( Figure S1B ). For all analyses performed, significance was defined as *p < 0.05; **p < 0.01; ***p < 0.001 and ns, not significant.
